Understanding lymphoma: Get the facts at a free virtual education event on Sept. 28

Understanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin

To highlight September as Lymphoma Awareness Month, Natasha Edwin, M.D., hematologist, medical oncologist at Providence Cancer Institute in partnership with Asian Health & Service Center shares the latest information about lymphoma and the types, risk factors, symptoms, diagnosis, staging, treatments and side effects.

Learn more about virtual educational talks and other community events.  

About Dr. Natasha Edwin

Dr. Natasha Edwin is a hematologist and medical oncologist at Providence Oncology and Hematology Care Clinic - Westside and specializes in the treatment of patients with blood cancer and blood disorders.

Dr. Edwin is passionate about putting her patients at ease by personalizing treatments, aligning them with their own values, and empowering them with the knowledge they need to make informed decisions about their care. She is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Edwin is a strong proponent of participation in clinical trials. She has served on the Leukemia Committee of the Eastern Cooperative Oncology Group and on the Board of Directors for the Alliance for Clinical trials in Oncology.

Experienced care for patients with cancer and blood disorders 

The Providence Hematologic Malignancies Program provides compassionate care for cancers of the blood, bone marrow and lymph nodes. We combine the most advanced therapies with new research to use your body's own immune system to fight cancer.

Our team of physicians are experts in hematologic malignancies including Hodgkin and non-Hodgkin lymphomas, leukemia, multiple myeloma and the myelodysplastic syndromes. We use a team approach to care because we know you’ll benefit most when you have the knowledge of many different specialists guiding your treatment. Learn more.

Related news

Multi-indication clinical trials help evaluate new medications for future treatments

Study to evaluate effect of immunotherapy in blood cancer

 

1/30/2023
Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
1/13/2023
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
12/20/2022
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
12/6/2022
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.